Rōvn · Investor Room
AI agent: checking…
All sections
Financials

Funding Benchmarks

Current truthRōvn master canon generation 8 · effective 2026-07-21. Earlier dated diligence documents are historical snapshots, not current deployment proof.Ask the canon-grounded agent →
AI Diligence Console

Benchmarks

Updated: 2026-07-22, aligned to Rōvn master canon generation 8 (effective 2026-07-21). Status: comparative benchmarks for category positioning. Cited from public sources where available; labeled (undisclosed) where private. Rōvn is pre-launch with zero revenue; nothing here is a Rōvn result.


1. Credentialing software (direct comps)

Vendor Founded Ownership Revenue / round (where public) Notes
symplr 2006 Clearlake Capital + Charlesbank revenue undisclosed Roll-up of multiple credentialing acquisitions; facility-side systems
Modio Health 2014 Acquired by CHG Healthcare (Oct 2019) undisclosed Credentialing CRM (OneView). Acquirer is CHG Healthcare, not HealthStream; terms not disclosed
Medallion 2020 VC-backed (Sequoia, Spark, GV, Acrew) ~$130M raised; ~$50.6M 2024 revenue (reported) Credentialing plus payer enrollment; SaaS-native
CertifyOS 2021 VC-backed (General Catalyst, Transformation Capital) ~$69M raised ($40M Series B, Jun 2025) API-first credentialing
Verifiable 2018 Independent, VC-backed (Craft Ventures) $27M Series B (2023); ~$50M total Healthcare verification API. Independent, not a Stripe acquisition

Rōvn positioning vs these comps, stated defensibly:

  • Worker-controlled, consent-gated evidence that persists across employers, versus facility-side records that stay inside one buyer's system.
  • Organization-specific authority: each facility applies its own requirements and keeps its own decision. Rōvn never universalizes an approval.
  • An operating loop, not a records product: one Resolution Case per issue, named-human decisions, signed receipts, and continued post-hire operation.
  • Neutral economics: no placement fee and no shift take rate, so Rōvn can work across hiring channels.
  • These are designed differentiators. Rōvn concedes that credential wallets, source networks, monitoring, and reuse programs already exist in this category (Axuall is the closest overlap; see 10.3 Competitive Landscape), and none of Rōvn's differentiators are proven in production today.

2. Workforce / staffing comps (adjacent)

Vendor Founded Public/Private Revenue (where public) Notes
Trusted Health 2017 Private (a16z, Felicis, Stepstone) (undisclosed) Travel nurse staffing marketplace
Vivian Health 2019 Acquired by IAC 2021 (undisclosed) Healthcare jobs marketplace
ShiftKey 2016 Private (Lorient Capital) (undisclosed) Per-diem healthcare staffing; credential reuse inside its marketplace
Aya Healthcare 2001 Private $5B+ revenue (widely cited) Largest healthcare staffing company in the US

Rōvn positioning: Rōvn is not a staffing agency, takes no placement fee, and holds no shift book. Staffing platforms and agencies are potential participants that can read governed state under consent through READ, not competitors Rōvn replaces. Gig marketplaces already prove clinicians value credential reuse inside a marketplace; Rōvn's narrower claim is governed reuse across employers outside any single marketplace, and that claim is unproven until measured.


3. Identity / verification comps (analog)

Vendor Founded Valuation Notes
Plaid 2013 ~$8.0B (2026 tender; $13.4B 2021 peak) Financial-data network
Persona 2018 ~$2.0B (Series D, 2025; prior $1.5B 2021) Identity verification
CLEAR 2010 $4B+ market cap Identity verification
Verifiable 2018 Independent · $27M Series B (2023) Healthcare verification API

What the analogy is and is not: Plaid and Persona show that verification networks earn premium multiples when reuse density and switching costs compound. Rōvn's version of that mechanic is the falling cost of the second Work Activation, and it is a designed mechanic, not a measured one. The healthcare regulatory surface (NCQA, Joint Commission and CMS survey standards, NPDB, DEA, state boards) is the depth a horizontal provider does not carry; it is also the reason healthcare adoption is slower.


4. SaaS metrics benchmarks (industry reference)

Metric Pre-seed Seed to Series A Rōvn today
ARR at Series A $1-2M $1-3M typical for vertical SaaS $0, pre-launch
Gross retention 80%+ 90%+ Nothing measured
Net retention 100%+ 120%+ Nothing measured
Gross margin 60-70% 70-80% Nothing measured; cost per completed Work Activation is the internal margin metric

Industry columns per OpenView SaaS Benchmarks 2024 and ChartMogul SaaS Benchmarks 2024. Rōvn target values are set with the board once a first paying cohort exists.


5. Round context

Indicative market ranges for healthcare vertical software (directional, not offers): pre-seed $1-3M, seed $4-8M, Series A $12-25M.

Rōvn's plan of record is milestone-based rather than range-shopping: a YC $500K bridge if accepted, lean Phase 0 burn of roughly $58K per month, and an intended post-Demo-Day seed modeled at roughly $5M sized against actual proof, burn, and the NCQA-CVO path. If YC declines, an independent lean pre-seed against the same milestones. Terms stay silent until counsel confirms the offering exemption. See 02.1 Use of Funds.


6. Acquisition / strategic comparables

Acquirer Target Year Price Notes
CHG Healthcare Modio Health 2019 undisclosed Credentialing CRM; terms not disclosed
Clearlake / Charlesbank symplr (roll-up history) multiple $1.25B+ total Serial credentialing roll-up
Datavant Ciox Health 2021 ~$7B Health-data adjacent
IAC Vivian Health 2021 undisclosed Healthcare jobs marketplace

Verifiable is independent ($27M Series B, Craft Ventures, 2023); there is no Stripe/Verifiable transaction. Do not list it as an acquisition.

Strategic context: vertical-SaaS strategics (HealthStream, symplr, Workday, UKG) and health-data strategics (Datavant, Cotiviti) have all transacted in or adjacent to this category. The capture pattern is also a warning the company plans around: neutral credential assets have repeatedly been absorbed by one side of the market (CAQH by payers, Kamana by Triage, Modio by CHG). Rōvn's defense is worker ownership of the consent-gated record. No exit valuation is modeled here; earlier exit framing derived from the retired revenue model is withdrawn.


7. Market sizing reference

Market sizing, with sources and dates, lives in 10.1 Market Opportunity. This page deliberately repeats none of those numbers; benchmarks and sizing decay at different speeds and are maintained in one place each.


8. Sources

  • OpenView SaaS Benchmarks 2024; ChartMogul SaaS Benchmarks 2024
  • NSI Nursing Solutions, 2026 National Health Care Retention and RN Staffing Report (2025 hospital performance: 78 days average experienced-RN recruitment, 8.6 percent RN vacancy, $60,090 average cost per RN turnover)
  • AAPPR 2025 recruiting benchmark (median time-to-fill: 118 days physicians, 77 days APPs)
  • BLS 2024 Occupational Outlook (healthcare workforce sizing; BLS wage categories used elsewhere are labeled proxies)
  • CHG Healthcare announcement, Modio Health acquisition (2019)
  • Craft Ventures / TechCrunch, Verifiable Series B (2023)
  • NCQA Credentialing Accreditation (2024 revision); Joint Commission / CMS surveyor PSV standards; CMS 60-Day Overpayment Rule (42 CFR 401.305)
Ask the AI agent about this section, the raise, compliance posture, or any cross-document question. Grounded in Rōvn canon generation 8, with on-page source citations.

Investor questions run through Google Cloud Vertex AI and are constrained to the hash-pinned Rōvn generation 8 canon. No PHI belongs in this room or its prompts.